tiprankstipranks
Iperionx Ltd. ADR (IPX)
NASDAQ:IPX

Iperionx Ltd. ADR (IPX) AI Stock Analysis

91 Followers

Top Page

IPX

Iperionx Ltd. ADR

(NASDAQ:IPX)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - 5.2)
Rating:40Underperform
Price Target:
$26.00
▼(-4.52% Downside)
Action:ReiteratedDate:03/21/26
The score is primarily pressured by weak financial performance (pre-revenue, widening losses, and rising cash burn) and bearish technicals (price far below all major moving averages with weak momentum). Valuation contributes limited support because a negative P/E reflects losses and the dividend yield is not available.
Positive Factors
Low leverage and expanding equity base
Very low leverage reduces near-term refinancing risk and gives the company financial flexibility as it develops assets. An expanded equity base indicates the ability to raise capital to fund project build-out, supporting a multi-month runway for development and commercialization efforts.
Negative Factors
Pre-revenue operations with widening losses
No revenue despite large operating scale-up means the business hasn't demonstrated commercial traction. Widening net losses erode capital, increase reliance on financing, and raise execution risk over multiple quarters while stakeholders await proof of profitable demand or successful product commercialization.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage and expanding equity base
Very low leverage reduces near-term refinancing risk and gives the company financial flexibility as it develops assets. An expanded equity base indicates the ability to raise capital to fund project build-out, supporting a multi-month runway for development and commercialization efforts.
Read all positive factors

Iperionx Ltd. ADR (IPX) vs. SPDR S&P 500 ETF (SPY)

Iperionx Ltd. ADR Business Overview & Revenue Model

Company Description
IperionX Limited engages in the exploration and development of mineral properties. It explores for epithermal and replacement style precious and base metal mineralization, as well as titanium, rare earth elements, silica sand, and zircon minerals....
How the Company Makes Money
IperionX’s revenue model is primarily tied to commercializing titanium products and related materials processing. The company aims to make money by (1) selling titanium metal products—particularly titanium powders and potentially other titanium fo...

Iperionx Ltd. ADR Financial Statement Overview

Summary
Financials are dominated by pre-revenue operations, widening net losses (FY2025 net loss ~$35.3M vs. ~$22.2M FY2024), and accelerating cash burn (FY2025 operating cash flow about -$21.8M; free cash flow roughly -$39.4M). The main offset is a low-leverage balance sheet (debt-to-equity ~0.04) and expanding equity base, but ongoing losses imply continued funding/dilution risk.
Income Statement
8
Very Negative
Balance Sheet
56
Neutral
Cash Flow
18
Very Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue0.000.000.000.000.000.00
Gross Profit-2.68M-2.27M-648.22K-634.11K-152.90K-9.38K
EBITDA-72.49M-37.79M-22.49M-16.86M-21.64M-8.82M
Net Income-70.16M-35.35M-22.23M-17.44M-21.52M-13.28M
Balance Sheet
Total Assets129.16M105.03M55.44M22.80M9.91M2.79M
Cash, Cash Equivalents and Short-Term Investments65.83M54.81M33.16M11.94M5.67M1.70M
Total Debt4.46M3.93M1.49M975.31K543.03K475.65K
Total Liabilities20.95M12.59M4.10M2.24M2.49M1.03M
Stockholders Equity108.20M92.44M51.34M20.56M7.42M1.76M
Cash Flow
Free Cash Flow-53.61M-39.41M-26.68M-18.57M-14.06M-3.62M
Operating Cash Flow-18.98M-21.80M-18.68M-15.86M-12.13M-3.56M
Investing Cash Flow-18.96M-24.28M-6.53M-5.71M-3.07M1.76M
Financing Cash Flow925.04K67.99M46.59M27.89M19.39M3.50M

Iperionx Ltd. ADR Technical Analysis

Technical Analysis Sentiment
Negative
Last Price27.23
Price Trends
50DMA
41.07
Negative
100DMA
39.01
Negative
200DMA
40.48
Negative
Market Momentum
MACD
-4.90
Negative
RSI
39.10
Neutral
STOCH
87.47
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPX, the sentiment is Negative. The current price of 27.23 is below the 20-day moving average (MA) of 31.25, below the 50-day MA of 41.07, and below the 200-day MA of 40.48, indicating a bearish trend. The MACD of -4.90 indicates Negative momentum. The RSI at 39.10 is Neutral, neither overbought nor oversold. The STOCH value of 87.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IPX.

Iperionx Ltd. ADR Risk Analysis

Iperionx Ltd. ADR disclosed 51 risk factors in its most recent earnings report. Iperionx Ltd. ADR reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Iperionx Ltd. ADR Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
$1.25B-143.02-6.14%240.12%0.98%
50
Neutral
$760.52M-5.12-22.22%1.17%-16.89%-403.77%
49
Neutral
$3.47B-3.92-49.89%
48
Neutral
$8.84B-5.04%26.44%-95.87%
40
Underperform
$888.04M-0.87-35.30%-18.77%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IPX
Iperionx Ltd. ADR
27.23
13.44
97.46%
GSM
Ferroglobe
4.07
1.04
34.46%
UAMY
United States Antimony
8.69
6.68
332.34%
MP
MP Materials
49.73
25.74
107.29%
CRML
Critical Metals Corp
8.40
6.77
415.34%
USAR
USA Rare Earth
15.92
6.45
68.11%

Iperionx Ltd. ADR Corporate Events

IperionX Files December 2025 Half‑Year Results, Revealing Wider Interim Loss
Mar 12, 2026
On March 12, 2026, IperionX Limited filed a Form 6‑K with the U.S. Securities and Exchange Commission, lodging its unaudited condensed consolidated financial statements for the six months ended December 31, 2025, alongside its ASX half&#8209...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 21, 2026